Japan Shortens New Drug Approval Time By 4.5 Months
This article was originally published in PharmAsia News
Executive Summary
The Pharmaceutical and Medical Devices Agency announced its annual report showing that average time for new drug approval has been shortened by 4.5 months to 14.7 months